Cash balance is almost the same as a year ago. Huge increase in receivables. Something fishy here. Put a 25x multiple on this year's earnings and this is a $22 stock.
it's also showing almost 50% bottom line growth for next year. and an enterprise value that is just over 1x 2011 sales. not disagreeing with your earlier post..just pointing out that there are other valuation metrics that make zoll fairly compelling.
this is their last year for payout for lifecor..the cash will be flowing next year